Title:
THE USE OF THE MOLECULE HYDROQUINIDINE IN THE TREATMENT OF BRAIN TUMORS
Document Type and Number:
WIPO Patent Application WO/2023/177376
Kind Code:
A3
Abstract:
The present invention relates to the use of the molecule hydroquinidine as a drug candidate for the treatment of brain cancer and tumors and the relief of symptoms resulting from these diseases. The invention also discloses in vitro studies carried out by the inventors in this direction.
Inventors:
DEMIRCAN TURAN (TR)
YAVUZ MERVENUR (TR)
YAVUZ MERVENUR (TR)
Application Number:
PCT/TR2023/050230
Publication Date:
November 09, 2023
Filing Date:
March 08, 2023
Export Citation:
Assignee:
MUGLA SITKI KOCMAN UNIV IDARI MALI ISLER BASKANLIGI (TR)
International Classes:
A61P35/00; A61K31/4748
Domestic Patent References:
| WO2022051495A1 | 2022-03-10 |
Foreign References:
| US5635515A | 1997-06-03 | |||
| KR20210007066A | 2021-01-20 |
Other References:
E SOLARY , I VELAY, B CHAUFFERT, J M BIDAN, D CAILLOT, M DUMAS, H GUY: "Sufficient levels of quinine in the serum circumvent the multidrug resistance of the human leukemic cell line K562/ADM", CANCER, vol. 68, no. 8, 15 October 1991 (1991-10-15), US , pages 1714 - 1719, XP002587817, ISSN: 0008-543X, DOI: 10.1002/1097-0142(19911015)68:8<1714::aid-cncr2820680811>3.0.co;2-2
Attorney, Agent or Firm:
KAYA, Erdem (TR)
Download PDF: